| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/23/2006 | CA2564616A1 Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells |
| 02/22/2006 | EP1627925A1 Method for the determination of cellular transcriptional regulation by micro RNAs |
| 02/22/2006 | EP1627920A1 Method for the manufacture of recombinant trypsin |
| 02/22/2006 | EP1627919A1 An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 02/22/2006 | EP1627918A1 Antagonists of interleukin-15 |
| 02/22/2006 | EP1627917A1 NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO |
| 02/22/2006 | EP1627915A1 Array having substances fixed on support arranged with chromosomal order or sequence position information added thereto, process for producing the same, analytical system using the array and use of these |
| 02/22/2006 | EP1627887A2 Mouce trace amine associated receptors |
| 02/22/2006 | EP1627886A1 Polypeptide, cDNA encoding the same, and use of them |
| 02/22/2006 | EP1627885A1 Polypeptide capable of assisting digestive organ absorption |
| 02/22/2006 | EP1627686A1 Method for acceleration and intensification of target-receptor binding and device therefor |
| 02/22/2006 | EP1627563A1 Means and methods for producing a stabilized cell of interest |
| 02/22/2006 | EP1627225A2 Improved methods for protein interaction determination |
| 02/22/2006 | EP1627217A2 Cdkl1 as modifier of branching morphogenesis and methods of use |
| 02/22/2006 | EP1627080A2 Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection |
| 02/22/2006 | EP1627068A2 Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds |
| 02/22/2006 | EP1627067A1 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b |
| 02/22/2006 | EP1627066A2 Functional characterization of myo-inositol monophosphatase |
| 02/22/2006 | EP1627065A1 Modification of fatty acid biosynthesis using recombinant diacylglycerol acyltransferase sequences from ryegrass ( lolium ) and fescue ( festuca ) |
| 02/22/2006 | EP1627064A1 Flowering inhibition |
| 02/22/2006 | EP1627063A1 Flowering induction |
| 02/22/2006 | EP1627062A1 A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire |
| 02/22/2006 | EP1627061A2 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/22/2006 | EP1627059A2 Recombinant comamonas testosteroni 5-mgam-4d; amids and carboxylic acid production |
| 02/22/2006 | EP1627058A2 Bioreactor containing cells expressing glycosyltransferase nucleic acids |
| 02/22/2006 | EP1627057A2 Methods and compositions for the production of adenoviral vectors |
| 02/22/2006 | EP1627056A1 Novel il-8-like polypeptides |
| 02/22/2006 | EP1627050A2 Variant humicola grisea cbh1.1 |
| 02/22/2006 | EP1627049A2 Novel trichoderma genes |
| 02/22/2006 | EP1626993A2 Cd20-specific antibodies and methods of employing same |
| 02/22/2006 | EP1626991A2 Anti alpha-folate-receptor-tetramer antibodies |
| 02/22/2006 | EP1626988A2 Intron fusion proteins, and methods of identifying and using same |
| 02/22/2006 | EP1626985A1 Generation of artificial binding proteins based on ubiquitin proteins |
| 02/22/2006 | EP1626979A2 Genetically modified yeast species and fermentation processes using genetically modified yeast |
| 02/22/2006 | EP1626978A2 Polymerase-based protocols for the introductions of deletions and insertions |
| 02/22/2006 | EP1626732A2 Means for preventing and treating cellular death and their biological applications |
| 02/22/2006 | EP1626694A2 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry |
| 02/22/2006 | EP1626623A2 Method for cloning in the rat by nuclear transfer |
| 02/22/2006 | EP1626621A2 Plant breeding method |
| 02/22/2006 | EP1587869A4 Membrane active polymers |
| 02/22/2006 | EP1585985A4 Human pellino polypeptides |
| 02/22/2006 | EP1558741A4 Recombination of nucleic acid library members |
| 02/22/2006 | EP1537211A4 Isolated cytokine receptor licr-2 |
| 02/22/2006 | EP1523491A4 Maize clavata3-like polynucleotide sequences and methods of use |
| 02/22/2006 | EP1513392A4 A method for increasing resistance of monocot plants against abiotic stresses |
| 02/22/2006 | EP1481080A4 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics |
| 02/22/2006 | EP1470251A4 Exponential amplification of nucleic acids using nicking agents |
| 02/22/2006 | EP1463750A4 Plant cyclopropane fatty acid synthase genes, proteins and uses thereof |
| 02/22/2006 | EP1453961B1 Stabilisation of double-stranded nucleic acids using proteins |
| 02/22/2006 | EP1451368A4 Single nucleotide polymorphisms in gh-1 |
| 02/22/2006 | EP1436402B1 Coffee plant with reduced alpha-d-galactosidase activity |
| 02/22/2006 | EP1434882A4 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 02/22/2006 | EP1427807A4 Estrogen receptor alpha variants and methods of detection thereof |
| 02/22/2006 | EP1370668B1 Leporipox-based vector vaccines |
| 02/22/2006 | EP1276881B1 Methods for enhancing the expression of a protein of interest by recombinant host cells |
| 02/22/2006 | EP1244805B1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 02/22/2006 | EP1244803B1 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 02/22/2006 | EP1212464B1 Diagnostics and therapeutics for osteoporosis |
| 02/22/2006 | EP1194584B1 Method for producing oligopolysaccharides |
| 02/22/2006 | EP1131418B1 Alpha-amylase variants |
| 02/22/2006 | EP1121431B1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 02/22/2006 | EP1062336B1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 02/22/2006 | EP1047788B1 Method of determining metastatic potential employing the asp1 gene |
| 02/22/2006 | EP1040185B1 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 02/22/2006 | EP1003844B1 Kinase activating dependent cyclin protein kinases, and their uses |
| 02/22/2006 | EP1000161B1 Anticoagulant fusion protein anchored to cell membrane |
| 02/22/2006 | EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/22/2006 | EP0932682B1 BACILLUS THURINGIENSIS CryET29 COMPOSITIONS TOXIC TO COLEOPTERAN INSECTS AND CTENOCEPHALIDES SPP |
| 02/22/2006 | EP0805871B2 Anti-cd30 antibodies preventing proteolytic cleavage and release of membrane-bound cd30 antigen |
| 02/22/2006 | EP0796912B1 Novel lysine decarboxylase gene and process for producing l-lysine |
| 02/22/2006 | EP0787206B1 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS |
| 02/22/2006 | EP0722490B1 Amylase variants |
| 02/22/2006 | EP0656060B1 Androgen regulation with dna sequences of rat probasin gene |
| 02/22/2006 | EP0649537B2 Immunoassays for anti-hcv antibodies using antigens with conformational epitopes |
| 02/22/2006 | EP0549615B1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 02/22/2006 | CN1739030A Diagnosis and prevention of cancer cell invasion |
| 02/22/2006 | CN1738911A Solid surface for biomolecule delivery and high-throughput assay |
| 02/22/2006 | CN1738910A Expression profiling based on histocultures |
| 02/22/2006 | CN1738907A Process for detecting predisposition to a cardiovascular disease |
| 02/22/2006 | CN1738903A Immunization of fish with plant-expressed recombinant proteins |
| 02/22/2006 | CN1738902A Artificial promoter for the expression of DNA sequences in vegetal cells |
| 02/22/2006 | CN1738901A Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses |
| 02/22/2006 | CN1738900A Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/22/2006 | CN1738896A Composition and method for treating lupus nephritis |
| 02/22/2006 | CN1738834A Hcv 疫苗 Hcv vaccine |
| 02/22/2006 | CN1738833A Hcv疫苗 Hcv vaccine |
| 02/22/2006 | CN1738832A Ligands |
| 02/22/2006 | CN1738829A New 2',5'-oligoadenylic acid analog |
| 02/22/2006 | CN1738648A Small interference RNA gene therapy |
| 02/22/2006 | CN1738530A Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway |
| 02/22/2006 | CN1737160A Polynucleotide array and method for detecting target polynucleotide using the same |
| 02/22/2006 | CN1737156A Gene transfer methods |
| 02/22/2006 | CN1737155A Method for removing stage action extraneous gene in transgenic plant |
| 02/22/2006 | CN1737154A Multiple copy expression box recombinant yeast expression plasmid quick construction method |
| 02/22/2006 | CN1737153A Recombinant bacillus Calmette-Guerin vaccine and its preparation method |
| 02/22/2006 | CN1737152A Recombinant Ag85B bacillus Calmette-Guerin vaccine |
| 02/22/2006 | CN1737151A Wheat anti-powdery mildew gene Pm21 linked codorminant PCR marker and its usage |
| 02/22/2006 | CN1737150A Adiponectin-Glucagon-like peptide-1-like peptide recombinant protein expression vector and construction |
| 02/22/2006 | CN1737149A Directional evolution method using in separating anti-embolism substance, and anti emboism substance and purification method |
| 02/22/2006 | CN1737148A High affinity ammonium transport factor fuse gene and its use in transgenic plant |